Clinical Trial Update: Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a human embryonic stem cell–derived neural precursor cell therapy for Parkinson's disease. The study is a Phase 1/2 trial assessing saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HESC-derived Neural Precursor Cells (neural precursor cells derived from human embryonic stem cells)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: UNKNOWN